drugset / Trial / NCT00374192

The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women

NCT00374192

RandomizedCrossoverTriple-blindTreatment

Summary

To examine the change in sleep patterns and mood symptoms in response to eszopiclone (Lunesta) using a double-blind placebo-controlled cross-over study design in perimenopausal and postmenopausal women who experience insomnia, mild depression and/or anxiety.

Timeline

Start
2006-02
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Eszopiclone Small molecule 3 mg

Indications